FoxO3a Drives the Metabolic Reprogramming in Tamoxifen-Resistant Breast Cancer Cells Restoring Tamoxifen Sensitivity.

Cells · 2023 · PMC10742319 · PMID 38132097

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

On the other hand, ZR-75/TR only showed a trend toward a reduction in both glucose and oxygen consumption following FoxO3a over-expression ( Figure A1 e,f and Figure A2 e,f). 3.3.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.